How Should Providers Be Approaching the Generative AI Frenzy?

The U.S. healthcare sector has been slow to undergo digital transformation compared to other industries, leading to a lack of seamless digital experiences for consumers. Bill Fera of Deloitte highlighted the need for healthcare to move beyond electronic processes to true digital transformation, particularly through the use of generative AI. He emphasized the importance of…

Read More

Calls for nurses and midwives to be exempt from HSE recruitment moratorium

The Irish Nurses and Midwives Organisation (INMO) is urging the Health Service Executive (HSE) to lift the moratorium on recruiting frontline patient-facing staff due to a 13% increase in emergency department attendances. INMO General Secretary Phil Ní Sheaghdha highlighted that nurses and midwives are facing challenges and increased workload without additional staff. The lack of…

Read More

Hospitales de California y defensores buscan financiación estable para retener a navegadores de salud conductual

Los proveedores de salud y expertos en adicciones en California advierten que el programa CA Bridge, que ayuda a pacientes con trastornos por consumo de sustancias a iniciar tratamientos de largo plazo después de salir de salas de emergencia, enfrenta desafíos financieros. A pesar de sus beneficios comprobados en la reducción de muertes por sobredosis,…

Read More

Melatonin sent 11K children to ED in 4 years

A recent study found that 7 out of 10 ED visits for unsupervised medication exposures by infants and young children in the US were due to unsupervised ingestion of melatonin from 2019 to 2022. Many incidents involved flavored products like gummies, and in nearly half of visits, children ingested adult or family formulations of melatonin….

Read More

Amylyx ALS drug failure raises questions and concerns

The ALS community faces disappointment as Amylyx Pharmaceuticals’ drug Relyvrio fails to outperform a placebo in a study, raising questions about its approval in 2022. ALS advocate Mary Catherine Collet emphasizes the importance of facing the scientific data despite the setback. The drug generated significant revenue for the company, prompting discussions about its removal from…

Read More
error: Content is protected !!